Findings

What do systematic reviews say?

2,511 questions · 2,668 findings · 290 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 743 · 27.8%GRADE not reported 329 · 12.3%Very low 775 · 29%Low 484 · 18.1%Moderate 279 · 10.5%High 58 · 2.2%

Plate fixation vs tension band wiring

Adverse events ‐ heterotopic ossification (bone formation) · adults with olecranon fractures

It is very uncertain whether plate fixation changes adverse events ‐ heterotopic ossification (bone formation) compared with tension band wiring (very low certainty).

1 finding from 1 review

Surgical interventions for treating fractures of the olecranon in adults 2014 · Cochrane Headline outcomes only
RR 0.29
1 study · 41 participants
Very low

Subcutaneous closure vs no subcutaneous closure

Superficial wound dehiscence · participants having non‐caesarean surgery

It is very uncertain whether subcutaneous closure changes superficial wound dehiscence compared with no subcutaneous closure (very low certainty).

1 finding from 1 review

Subcutaneous closure versus no subcutaneous closure after non‐caesarean surgical procedures 2014 · Cochrane Headline outcomes only
RR 0.56 [0.22, 1.41]
2 studies · 215 participants
Very low

Subcutaneous closure vs no subcutaneous closure

Deep wound dehiscence · participants having non‐caesarean surgery

It is very uncertain whether subcutaneous closure changes deep wound dehiscence compared with no subcutaneous closure (very low certainty).

1 finding from 1 review

Subcutaneous closure versus no subcutaneous closure after non‐caesarean surgical procedures 2014 · Cochrane Headline outcomes only
RR 0.25 [0.03, 2.11]
1 study · 60 participants
Very low

Subcutaneous closure vs no subcutaneous closure

Length of hospital stay · participants having non‐caesarean surgery

1 finding from 1 review

Subcutaneous closure versus no subcutaneous closure after non‐caesarean surgical procedures 2014 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 434 participants
Very low

Open surgery vs ERCP

All‐cause mortality · with common bile duct stones

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 733 participants
Moderate

LC + LCBDE vs LC + post‐operative ERCP

Total morbidity · with common bile duct stones

LC + LCBDE showed no clear difference in total morbidity compared with LC + post‐operative ERCP (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 1.16 [0.5, 2.72]
2 studies · 166 participants
Moderate

LC + LCBDE vs LC + post‐operative ERCP

Failure of procedure · with common bile duct stones

LC + LCBDE showed no clear difference in failure of procedure compared with LC + post‐operative ERCP (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.47 [0.21, 1.06]
2 studies · 166 participants
Moderate

LC + LCBDE vs LC + post‐operative ERCP

Retained stones after primary intervention · with common bile duct stones

LC + LCBDE probably leads to lower retained stones after primary intervention compared with LC + post‐operative ERCP (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.28 [0.11, 0.72]
2 studies · 166 participants
Moderate

LC + LCBDE vs LC + post‐operative ERCP

Conversion to open surgery · with common bile duct stones

LC + LCBDE showed no clear difference in conversion to open surgery compared with LC + post‐operative ERCP (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 1.77 [0.23, 13.81]
2 studies · 166 participants
Moderate

Open surgery vs ERCP

Total morbidity · with common bile duct stones

Open surgery showed no clear difference in total morbidity compared with ERCP (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 1.12 [0.77, 1.62]
8 studies · 729 participants
Moderate

Open surgery vs ERCP

Failure of procedure · with common bile duct stones

Open surgery probably leads to lower failure of procedure compared with ERCP (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.32 [0.21, 0.48]
7 studies · 943 participants
Moderate

Open surgery vs ERCP

Retained stones after primary intervention · with common bile duct stones

Open surgery probably leads to lower retained stones after primary intervention compared with ERCP (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.36 [0.23, 0.57]
7 studies · 943 participants
Moderate

LC + LCBDE vs pre‐operative ERCP + LC

Mortality at 30 days · with common bile duct stones

LC + LCBDE showed no clear difference in mortality at 30 days compared with pre‐operative ERCP + LC (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.72 [0.12, 4.33]
5 studies · 580 participants
Moderate

LC + LCBDE vs pre‐operative ERCP + LC

Total morbidity · with common bile duct stones

LC + LCBDE showed no clear difference in total morbidity compared with pre‐operative ERCP + LC (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 1.28 [0.8, 2.05]
5 studies · 580 participants
Moderate

LC + LCBDE vs pre‐operative ERCP + LC

Failure of procedure · with common bile duct stones

LC + LCBDE showed no clear difference in failure of procedure compared with pre‐operative ERCP + LC (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.51 [0.16, 1.59]
5 studies · 580 participants
Moderate

LC + LCBDE vs pre‐operative ERCP + LC

Retained stones after primary intervention · with common bile duct stones

LC + LCBDE showed no clear difference in retained stones after primary intervention compared with pre‐operative ERCP + LC (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 0.79 [0.45, 1.39]
5 studies · 580 participants
Moderate

LC + LCBDE vs pre‐operative ERCP + LC

Conversion to open surgery · with common bile duct stones

LC + LCBDE showed no clear difference in conversion to open surgery compared with pre‐operative ERCP + LC (moderate certainty).

1 finding from 1 review

Surgical versus endoscopic treatment of bile duct stones 2013 · Cochrane Headline outcomes only
OR 1.46 [0.76, 2.81]
5 studies · 580 participants
Moderate

Intervention not reported

Lymph node mets analysis ‐ N+ OS · patients with resectable gastric cancer

The intervention probably leads to lower lymph node mets analysis ‐ N+ OS (moderate certainty).

1 finding from 1 review

Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer 2013 · Cochrane Headline outcomes only
HR 0.78 [0.67, 0.91]
4 studies · 877 participants
Moderate

Intervention not reported

Chemobased OS ‐ 5‐FU based chemotherapy OS · patients with resectable gastric cancer

The intervention probably leads to lower chemobased OS ‐ 5‐FU based chemotherapy OS (moderate certainty).

1 finding from 1 review

Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer 2013 · Cochrane Headline outcomes only
HR 0.88 [0.83, 0.94]
28 studies · 5694 participants
Moderate

Intervention not reported

Chemobased OS ‐ Platinum‐based chemotherapy OS · patients with resectable gastric cancer

The intervention showed no clear difference in chemobased OS ‐ Platinum‐based chemotherapy OS (moderate certainty).

1 finding from 1 review

Post‐surgical chemotherapy versus surgery alone for resectable gastric cancer 2013 · Cochrane Headline outcomes only
HR 0.9 [0.81, 1]
9 studies · 1504 participants
Moderate